Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans.

@article{Fischer2003EconomicCO,
  title={Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans.},
  author={Michael A. Fischer and Jerry Avorn},
  journal={Health services research},
  year={2003},
  volume={38 4},
  pages={
          1051-63
        }
}
OBJECTIVE To calculate the financial impact of underuse of generic medications in state Medicaid programs. DATA SOURCES/STUDY SETTING State-by-state data on Medicaid drug spending for 48 states and the District of Columbia in calendar year 2000. STUDY DESIGN We compared the total amount paid by each state Medicaid program for brand name prescriptions with the amount that would have been paid for generic versions of the same agent, to estimate the level of unrealized savings from use of… CONTINUE READING
Highly Cited
This paper has 70 citations. REVIEW CITATIONS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

70 Citations

0510'07'10'13'16'19
Citations per Year
Semantic Scholar estimates that this publication has 70 citations based on the available data.

See our FAQ for additional information.